Gregory John Woodhead MD, PhD, Presenter: Nothing to Disclose

Ragni Jindal BA, Abstract Co-Author: Nothing to Disclose

Bobby Thomas Kalb MD, Abstract Co-Author: Nothing to Disclose

Charles T. Hennemeyer MD, Abstract Co-Author: Nothing to Disclose

The purposes of this exhibit are: 1. To review irreversible electroporation (IRE), an evolving technique for the percutaneous ablation of malignant hepatic tumors. 2. To gain an awareness of how recent advances in abdominal MRI facilitate analysis of tissue imaging outcomes following percutaneous ablation. 3. To outline the systematic methodology employed at our institution for the characterization of post-IRE tissue outcomes.

I. Overview of percutaneous ablation of hepatic tumors: IRE, RFA, microwave ablation, and cryoablation. II. IRE: Applications, advantages, and technique. III. Abdominal MRI: A superior imaging modality for the characterization of hepatic tumors and evaluation of post-ablation tissue imaging outcomes: HCC and hepatic metastases. IV. “How we do it”: A systematic methodology for MRI evaluation and characterization of post-ablation outcomes. V. Through case examples, interpreting physicians will be introduced to broad categories of MR imaging outcomes following IRE: (1) Devascularization, and (2) Residual enhancement. IV. Summary: Recent advances in Body MRI facilitate analysis of post-ablation tissue characteristics. This educational exhibit will outline a methodology for the systematic evaluation of MRI outcomes following IRE of malignant hepatic tumors.

http://abstract.rsna.org/uploads/2014/14003676/14003676_dyrv.pdf

Woodhead, G, Jindal, R, Kalb, B, Hennemeyer, C, How We Do It: MRI Analysis of Tissue Imaging Outcomes Following Percutaneous Ablation of Hepatic Tumors.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14003676.html